Category: Monocyte-to-lymphocyte ratio

COVID-19 infections may actually shrink cancerous tumors, shock study reveals

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 infections may actually shrink cancerous tumors, shock study reveals

By The Conversation, Research led by Justin Stebbing, Anglia Ruskin University A fascinating new study, published in the Journal of Clinical Investigation, has revealed an unexpected potential benefit of severe COVID infection: it may help shrink cancer. This surprising finding, based on research conducted in mice, opens up new possibilities for cancer treatment and sheds light on the complex interactions […]

Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 

Posted on | Posted on John Murphy | Leave a Comment on Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 

Stefania Campana; Claudia De Pasquale; Giacomo Sidoti Migliore;, et. al. J Immunol (2022) 209 (4): 655–659. https://doi.org/10.4049/jimmunol.2200021 Abstract Proinflammatory monocytes play a preponderant role in the development of a cytokine storm causing fatal consequences in coronavirus disease 2019 (COVID-19) patients, highlighting the importance of analyzing in more detail monocyte distribution in these patients. In this study, […]

Post-COVID Interstitial Lung Disease—The Tip of the Iceberg

Posted on | Posted on John Murphy | Leave a Comment on Post-COVID Interstitial Lung Disease—The Tip of the Iceberg

Namrata Kewalramani, MD,a,b,∗ Kerri-Marie Heenan, MB Bch, BAO,c Denise McKeegan, MB Bch, BAO, MSc,c and Nazia Chaudhuri, MD, PhDd Immunol Allergy Clin North Am. 2023 May; 43(2): 389–410. Published online 2023 Mar3. doi: 10.1016/j.iac.2023.01.004 PMCID: PMC9982726PMID: 37055095 The proportion of symptomatic patients with post-coronavirus 2019 (COVID-19) condition (long COVID) represents a significant burden on the individual as well as on the health care systems. […]